Table 1. Differentially expressed LncRNAs resulting from SAM analyses comparing N with MGUS, sMM, MM, or PCL patients.
lncRNA | N | MGUS | SMM | MM | PCL | Chr | ALIAS; OVERLAPPING TRANSCRIPTa | Corr. lncRNA- transcriptb | PsGc | Putative Parental Gene | Corr. lncRNA- parental geneb |
---|---|---|---|---|---|---|---|---|---|---|---|
AC100793.1-1 | ↑ | ↓ | ↓ | ↓ | ↓ | 17q21 | RAMP2-AS1 | ||||
ATL3-1 | ↑ | ↓ | ↓ | ↓ | ↓ | 11q13 | C11orf95 | ||||
ADAP2-2 | ↑ | ↓ | ↓ | ↓ | ↓ | 17q11 | RN7SL138P | M | RN7SL (14q21) | NA | |
STOM-7 | ↑ | ↓ | ↓ | ↓ | 9q33 | GGTA1P | UP | ||||
HSFY2-10 | ↑ | ↓ | ↓ | ↓ | Yq11 | CD24P4; S to CD24 | NA | PP | CD24 (Yq11) | NA | |
CISH-3 | ↑ | ↓ | ↓ | ↓ | 3p21 | ZNF652P1; AS to DOCK3 | R=0.053 | PP | ZNF652 (17q21) | R=0.65 p<2.2e-16 | |
LRRC47-1 | ↑ | ↓ | ↓ | ↓ | 1p36 | TP73-AS1; AS to TP73 | R=0.03 | ||||
SEL1L3-6 | ↑ | ↓ | ↓ | ↓ | 4p15 | UnP | NA | ||||
SEMA4B-4 | ↑ | ↓ | ↓ | ↓ | 15q26 | ||||||
PQLC2-5 | ↑ | ↓ | ↓ | ↓ | 1p36 | RN7SL277P; AS to CAPZB | R= − 0.26 | M | RN7SL (14q21) | NA | |
SNURF-1 | ↑ | ↓ | ↓ | ↓ | 15q11 | S to SNORD115-116 family | NA | ||||
SNURF-3 | ↑ | ↓ | ↓ | ↓ | 15q11 | S to SNORD115-116 family | NA | ||||
APC-6 | ↓ | ↑ | ↑ | ↑ | ↑ | 5q22 | EPB41L4A-AS1; S to SNORA13 | NA | |||
MON2-2 | ↓ | ↑ | ↑ | ↑ | ↑ | 12q14 | S to Let7i | NA | |||
ARFIP1-5 | ↓ | ↑ | ↑ | ↑ | ↑ | 4q13 | AS to FBXW7, S to MIR4453 | R=0.03 (FBXW7) | |||
PTPDC1-7 | ↓ | ↑ | ↑ | ↑ | 9q22 | AS to MIRLET7DHG | NA | ||||
MC2R-2 | ↓ | ↑ | ↑ | ↑ | 18p11 | PP | RPL36A (Xq22) | NA | |||
SAFB2-3 | ↓ | ↑ | ↑ | ↑ | 19p13 | SNRPEP4 | PP | SNRPE (1q32) | R=0.5 p =0.030 |
||
SYT8-3 | ↓ | ↑ | ↑ | ↑ | 11p15 | RPL36AP39 | PP | RPL36A (Xq22) | NA | ||
CHRDL2-3 | ↓ | ↑ | ↑ | ↑ | 11q13 | PP | RPS12 (6q23) | R=0.17 | |||
SCYL1-1 | ↓ | ↑ | ↑ | ↑ | 11q13 | MALAT1 | |||||
TRPV2-1 | ↓ | ↑ | ↑ | ↑ | 17p11 | LRRC75A-AS1; S to SNORD49B, 49A, 65 | NA | ||||
LIPG-3 | ↓ | ↑ | ↑ | ↑ | 18q21 | SNHG22 | |||||
USP25-2 | ↓ | ↑ | ↑ | ↑ | 21q21 | S to SNORD74, MIR99AHG | NA | ||||
C3orf25-2 | ↓ | ↑ | ↑ | ↑ | 3q21 | RPL32P3; S to SNORA7B | NA | UnP | RPL32 (3p25) | R=0.47 p<2.2e-16 | |
AP1M2-1 | ↓ | ↑ | ↑ | ↑ | 19p13 | ILF3-AS1 | |||||
ANGPTL1-3 | ↓ | ↑ | ↑ | ↑ | 1q25 | AS to RALGPS2 | R=0.3 p=3.8e-08 |
||||
SENP5-4 | ↓ | ↑ | ↑ | ↑ | 3q29 | NCBP2 -AS2 | |||||
PAIP1-3 | ↓ | ↑ | ↑ | ↑ | 5p12 | RPL29P12; AS to NNT | R= − 0.054 | PP | RPL29 (3p21) | R=0.7 p<2.2e-16 | |
ABCB5-3 | ↓ | ↑ | ↑ | ↑ | 7p21 | RPL23P8 | PP | RPL23 (17q12) | NA | ||
RLIM-6 | ↓ | ↑ | ↑ | ↑ | Xq13 | AS to SLC16A2 | R=0.37 p=3.7e-10 |
Arrows indicate lncRNA expression, upregulation (↑) or downregulation (↓), in the corresponding group. Chromosomal localization (Chr), alias name, and overlapping transcripts are indicated.
Sense (S) to, or Antisense (AS) to overlapping transcripts;
Pearson correlation coefficient; NA =not available (not detected by the array);
PsG=Pseudogene; Ensembl type: PP= Processed Pseudogene; UP= Unitary Pseudogene;UnP= Unprocessed Pseudogene; M= miscellaneous RNA.